Sigma Planning Corp Sorrento Therapeutics, Inc. Transaction History

Sigma Planning Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 28, 2021	BUY	$7.41 - $10.99 $8,225 - $12,198	1,110 Added 8.33%	14,440 $110,000
Q2 2021 Aug 13, 2021	SELL	$6.35 - $10.0 $13,017 - $20,500	-2,050 Reduced 13.33%	13,330 $129,000
Q1 2021 May 06, 2021	BUY	$7.03 - $16.51 $27,627 - $64,884	3,930 Added 34.32%	15,380 $127,000
Q4 2020 Feb 09, 2021	SELL	$5.76 - $11.95 $47,001 - $97,512	-8,160 Reduced 41.61%	11,450 $78,000
Q3 2020 Nov 03, 2020	BUY	$6.17 - $18.82 $120,993 - $369,060	19,610 New	19,610 $219,000

Q3 2019 Nov 01, 2019	SELL	$2.05 - $2.69 $85,074 - $111,635	-41,500 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$2.67 - $4.38 $2,670 - $4,380	1,000 Added 2.47%	41,500 $111,000
Q1 2019 May 01, 2019	BUY	$1.86 - $5.94 $37,665 - $120,285	20,250 Added 100.0%	40,500 $192,000
Q4 2018 Jan 31, 2019	BUY	$2.01 - $4.24 $2,009 - $4,240	1,000 Added 5.19%	20,250 $49,000
Q2 2018 Aug 02, 2018	BUY	$4.75 - $8.0 $22,562 - $38,000	4,750 Added 32.76%	19,250 $139,000
Q1 2018 May 11, 2018	BUY	$4.5 - $9.95 $65,250 - $144,275	14,500 New	14,500 $75,000

5.51M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.